Cardiorenal effects of an orally active dopamine prodrug (TA-870) in patients with congestive heart failure. (Q54351027)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Cardiorenal effects of an orally active dopamine prodrug (TA-870) in patients with congestive heart failure. |
scientific article |
Statements
Cardiorenal effects of an orally active dopamine prodrug (TA-870) in patients with congestive heart failure (English)
J Kubota
S Kubo
H Nishimura
M Ueyama
M Kino
A Nakayama
M Hara
1 July 1989